Larson R - Search Results

1

High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.

Bradley J, Reft C, Goldman S, Rubin C, Nachman J, Larson R, Hallahan DE. Bradley J, et al. Among authors: larson r. Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):391-6. doi: 10.1016/s0360-3016(97)00578-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9457826

2

Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Farag SS, Archer KJ, Mrózek K, Vardiman JW, Carroll AJ, Pettenati MJ, Moore JO, Kolitz JE, Mayer RJ, Stone RM, Larson RA, Bloomfield CD. Farag SS, et al. Int J Oncol. 2002 Nov;21(5):1041-51. Int J Oncol. 2002. PMID: 12370753

3

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Smith SM, et al. Blood. 2003 Jul 1;102(1):43-52. doi: 10.1182/blood-2002-11-3343. Epub 2003 Mar 6. Blood. 2003. PMID: 12623843 Free article.

4

Progress and challenges in the therapy of adult acute lymphoblastic leukemia.

Kebriaei P, Larson RA. Kebriaei P, et al. Curr Opin Hematol. 2003 Jul;10(4):284-9. doi: 10.1097/00062752-200307000-00006. Curr Opin Hematol. 2003. PMID: 12799534 Review.

5

Kebriaei P, Winter JN, Laport GG, Le Beau MM, Dewald G, Larson RA. Kebriaei P, et al. Leuk Res. 2004 May;28(5):537-40. doi: 10.1016/j.leukres.2003.09.010. Leuk Res. 2004. PMID: 15068908

6

Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.

Stock W, Yu D, Karrison T, Sher D, Stone RM, Larson RA, Bloomfield CD. Stock W, et al. Int J Oncol. 2006 May;28(5):1099-103. Int J Oncol. 2006. PMID: 16596225

7

Management of acute lymphoblastic leukemia in older patients.

Larson RA. Larson RA. Semin Hematol. 2006 Apr;43(2):126-33. doi: 10.1053/j.seminhematol.2006.01.007. Semin Hematol. 2006. PMID: 16616046 Review.

8

Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.

Odenike OM, Larson RA, Gajria D, Dolan ME, Delaney SM, Karrison TG, Ratain MJ, Stock W. Odenike OM, et al. Invest New Drugs. 2008 Jun;26(3):233-9. doi: 10.1007/s10637-008-9115-6. Epub 2008 Jan 24. Invest New Drugs. 2008. PMID: 18217206 Free PMC article. Clinical Trial.

9

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.

Stock W, La M, Sanford B, Bloomfield CD, Vardiman JW, Gaynon P, Larson RA, Nachman J; Children's Cancer Group; Cancer and Leukemia Group B studies. Stock W, et al. Blood. 2008 Sep 1;112(5):1646-54. doi: 10.1182/blood-2008-01-130237. Epub 2008 May 23. Blood. 2008. PMID: 18502832 Free PMC article. Clinical Trial.

10

Therapy-related myeloid leukemia.

Godley LA, Larson RA. Godley LA, et al. Semin Oncol. 2008 Aug;35(4):418-29. doi: 10.1053/j.seminoncol.2008.04.012. Semin Oncol. 2008. PMID: 18692692 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,826 results

Search Page